Evaluation of CD38 Expression in T-cell Lymphoproliferative Disorders

被引：0
作者：
Grant, Michelle L. [1 ]
Lunde, John H. [1 ]
Devitt, Katherine A. [1 ]
Gardner, Juli-Anne [1 ]
机构：
[1] Univ Vermont, Med Ctr, Burlington, VT USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1413
引用
收藏
页码：352A / 352A
页数：1
相关论文
共 50 条
  • [31] Targeting CD38 with isatuximab and a novel CD38/CD3xCD28 trispecific T-cell engager in older patients with acute myeloid leukemia
    Martin-Sanchez, Esperanza
    Blanco, Laura
    Kim, Peter S.
    Bisht, Kamlesh
    Wang, Hongfang
    van de Velde, Helgi
    Jelinek, Tomas
    Simoes, Catia
    Prosper, Felipe
    Miguel, Jesus F. San
    Alfonso, Ana
    Bergua, Juan
    Rodriguez-Veiga, Rebeca
    Vives, Susana
    Martinez-Cuadron, David
    Montesinos, Pau
    Paiva, Bruno
    Zabaleta, Aintzane
    BLOOD ADVANCES, 2024, 8 (15) : 3875 - 3879
  • [32] CD38 and autism spectrum disorders
    Higashida, H.
    Munesue, T.
    JOURNAL OF NEUROCHEMISTRY, 2012, 123 : 4 - 5
  • [33] Daratumumab Efficiently Targets NK/T Cell Lymphoma with High CD38 Expression
    Mustafa, Nurulhuda
    Nee, Huey Fang Adina
    Lee, Xue Ting Jeannie
    Jin, Wei
    Yu, Yiling
    Chen, Yingnan
    Yang, Jennifer
    Chng, Wee Joo
    BLOOD, 2017, 130
  • [34] T-CELL RECEPTOR (TCR) GENE ANALYSIS IN T-CELL LYMPHOPROLIFERATIVE DISORDERS
    FORONI, L
    FOLDI, J
    MATUTES, E
    MORILLA, R
    RABBITTS, TH
    CATOVSKY, D
    LUZZATTO, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (03) : 412 - 412
  • [35] T-cell receptor-δ expression and γδ plus T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders
    Pulitzer, Melissa
    Geller, Shamir
    Kumar, Erica
    Frosina, Denise
    Moskowitz, Alison
    Horwitz, Steven
    Myskowski, Patricia
    Kheterpal, Meenal
    Chan, Alexander
    Dogan, Ahmet
    Jungbluth, Achim
    HISTOPATHOLOGY, 2018, 73 (04) : 653 - 662
  • [36] T-cell receptor delta rearrangements are present in normal cord blood CD34(+) CD38(dim) cells, not CD34(-) CD38(-) cells.
    Kerkof, KN
    Shah, AJ
    Smogorzewska, EM
    Smith, S
    Crooks, GM
    Weinberg, KI
    BLOOD, 1995, 86 (10) : 642 - 642
  • [37] T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells
    Mihara, Keichiro
    Bhattacharyya, Joyeeta
    Kitanaka, Akira
    Ihara, Akihiro
    Sakai, Akira
    Kuroda, Yoshiaki
    Asaoku, Hideki
    Takihara, Yoshihiro
    Kimura, Akiro
    BLOOD, 2011, 118 (21) : 405 - 405
  • [38] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
    Mihara, K.
    Bhattacharyya, J.
    Kitanaka, A.
    Yanagihara, K.
    Kubo, T.
    Takei, Y.
    Asaoku, H.
    Takihara, Y.
    Kimura, A.
    LEUKEMIA, 2012, 26 (02) : 365 - 367
  • [39] A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders
    Kempf, Werner
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2017, 34 (01) : 22 - 35
  • [40] CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas
    Pavlova, Olesya
    Tsai, Yi-Chien
    Chang, Yun-Tsan
    Eisenring, Maya Vonow
    Guenova, Emmanuella
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (07) : 1122 - 1126
12345